Cannabis linked to newborn withdrawal in Danish study

This Danish study examined the incidence of neonatal abstinence syndrome (NAS)—a withdrawal condition in newborns exposed to drugs in utero—across Eastern Denmark from 2013 to 2018. Researchers tracked how many infants developed NAS and investigated which prenatal drug exposures were associated with the condition. The findings showed that NAS incidence remained stable over the five-year period, contrary to rising trends reported in other countries, providing important epidemiological data on this serious newborn health concern.

The research identified cannabis as sometimes associated with NAS cases, though the study focused primarily on documenting the broader pattern of drug exposures linked to the condition. This finding is significant because it adds to the growing body of evidence suggesting that prenatal cannabis exposure may have measurable effects on newborn health outcomes. The stability in NAS rates in Denmark contrasts with concerning increases seen elsewhere, suggesting that regional differences in drug use patterns, healthcare practices, or population demographics may play important roles in determining NAS incidence.

These results have practical implications for pregnant individuals and healthcare providers, emphasizing the importance of monitoring prenatal substance exposure—including cannabis—and its potential effects on newborn health. The study contributes valuable real-world data to the ongoing conversation about cannabis safety during pregnancy, particularly as more regions legalize or decriminalize cannabis use.